The von Hippel-Lindau tumor suppressor gene product promotes, but is not essential for, NEDD8 conjugation to Cullin-2

被引:26
作者
Wada, H
Yeh, ETH
Kamitani, T
机构
[1] Univ Texas, Hlth Sci Ctr, Div Mol Med, Dept Internal Med, Houston, TX 77030 USA
[2] Univ Texas, Res Ctr Cardiovasc Dis, Inst Mol Med, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.274.50.36025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously shown that human cullin-2 (Cul-2) is covalently modified at Lys-689 by NEDD8 (Wada, H., Yeh, E. T. H., and Kamitani, T. (1999) Biochem. Biophys. Res. Commun. 257, 100-105). Cul-2 has also been reported to form a multiprotein complex, Cul-2 VBC, with the von Hippel-Lindau tumor suppressor gene product (pVHL) and elongins B and C. In this study, using an in vivo coexpression system in COS cells, we show that NEDD8 conjugation to Cul-2 is promoted by coexpression with wild-type pVHL and elongins B and C. Interestingly, tumorigenic mutants and deletion mutants of pVHL, which are unable to form a Cul-2 VBC complex, do not have the activity to promote NEDD8 conjugation to Cul-2, These results suggest that the complex formation is required for NEDD8 conjugation to Cul-2. Furthermore, we used a pVHL-deficient cell. line, 786-0, to show that Cul-2 is poorly but clearly conjugated by NEDD8, indicating that pVHL is not the only molecule that promotes NEDD8 conjugation to Cul-2. Taken together, the VBC complex appears to have ligase activity in the conjugation of NEDD8 to Cul-2.
引用
收藏
页码:36025 / 36029
页数:5
相关论文
共 37 条
[21]   CLONING OF A CDNA WHICH ENCODES A NOVEL UBIQUITIN-LIKE PROTEIN [J].
KUMAR, S ;
YOSHIDA, Y ;
NODA, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (01) :393-399
[22]   The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin [J].
Latres, E ;
Chiaur, DS ;
Pagano, M .
ONCOGENE, 1999, 18 (04) :849-854
[23]   Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function [J].
Liakopoulos, D ;
Büsgen, T ;
Brychzy, A ;
Jentsch, S ;
Pause, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5510-5515
[24]  
LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564
[25]   Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2 [J].
Lonergan, KM ;
Iliopoulos, O ;
Ohh, M ;
Kamura, T ;
Conaway, RC ;
Conaway, JW ;
Kaelin, WG .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (02) :732-741
[26]   A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2 [J].
Mahajan, R ;
Delphin, C ;
Guan, TL ;
Gerace, L ;
Melchior, F .
CELL, 1997, 88 (01) :97-107
[27]   A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex [J].
Matunis, MJ ;
Coutavas, E ;
Blobel, G .
JOURNAL OF CELL BIOLOGY, 1996, 135 (06) :1457-1470
[28]   The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis [J].
Maxwell, PH ;
Wiesener, MS ;
Chang, GW ;
Clifford, SC ;
Vaux, EC ;
Cockman, ME ;
Wykoff, CC ;
Pugh, CW ;
Maher, ER ;
Ratcliffe, PJ .
NATURE, 1999, 399 (6733) :271-275
[29]  
Okura T, 1996, J IMMUNOL, V157, P4277
[30]   A new NEDD8-ligating system for cullin-4A [J].
Osaka, F ;
Kawasaki, H ;
Aida, N ;
Saeki, M ;
Chiba, T ;
Kawashima, S ;
Tanaka, K ;
Kato, S .
GENES & DEVELOPMENT, 1998, 12 (15) :2263-2268